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Abstract.  Ligand affinity chromatography was used to 
purify a cell surface a2-macroglobulin (ot2M) receptor. 
Detergent extracts of human placenta were applied to 
an affinity matrix consisting of ot2M, previously 
reacted with methylamine,  coupled to Sepharose.  Elu- 
tion with EDTA specifically released polypeptides with 
apparent molecular masses of 420 and 39 kD.  In some 
preparations,  small amounts of a 90-kD polypeptide 
were observed. The 420- and 39-kD polypeptides ap- 
pear specific for the forms of ~2M activated by reac- 
tion with proteinases or methylamine and do not bind 
to an affinity matrix consisting of native ot2M coupled 
to Sepharose.  Separation of these two polypeptides 
was accomplished by anion exchange chromatography, 
and binding activity was exclusively associated with 
the 420-kD polypeptide. The purified 420-kD protein 
binds to the conformationally altered forms of ot2M 
that are known to specifically interact with o~2M recep- 
tors and does not bind to native c~2M. Binding of the 
420-kD polypeptide to immobilized wheat germ agglu- 
tinin  indicates that this polypeptide is a glycoprotein. 
The cell surface localization of the 420-kD glycopro- 
tein was confirmed by affinity chromatography of ex- 
tracts from surface radioiodinated fibroblasts. These 
properties suggest that the 420-kD polypeptide is a 
cell surface receptor for the activated forms of ~zM. 
Ot2-MACROGLOBULIN  (ot2M)' is a 718,000-mol  wt glycopro- 
tein that is capable of inhibiting enzymes from all four classes 
of proteinases  (2) in a reaction that is essentially irreversible. 
The reaction of proteinases or methylamine  with c~2M "acti- 
vates" the molecule by inducing  conformational  changes  in 
o~2M (3, 4,  16, 49) that,  in the case of the proteinase reac- 
tion, reduce the activity of the bound enzyme toward large 
molecular weight substrates.  These conformational changes 
also generate sites on the inhibitor that result in specific rec- 
ognition  by cell surface receptors (31, 52, 54). It has been 
possible to prepare monoclonal antibodies that  selectively 
recognize the activated forms of u2M (34, 50) by binding to 
these newly generated regions  (25). 
In addition  to regulating  proteinase activity,  studies  have 
suggested  that  c~2M binds to TGFfl (41), PDGF (22), and 
bFGF (7).  The  association of these molecules with ot2M 
results in a reduction of their activity,  suggesting that a2M 
may serve not only to modulate proteinase activity but also 
the activity of these molecules. Interestingly,  it appears that 
several tumor-derived or virus-transformed  cell lines are de- 
void of specific  cell surface receptors for t~2M-proteinase 
complexes (52). 
The process of receptor-mediated endocytosis has been the 
subject of extensive  study, and the mechanisms involved in 
I.  Abbreviations  used  in  this paper:  ct2M,  ~2-macroglobulin; t~2M:Me, 
methylamine-treated ~2-macroglobulin; NRK, normal rat kidney. 
endocytosis have been investigated using a variety of labeled 
ligands (6), including  transferrin  (20),  low density lipopro- 
tein (1), EGF (20), and ot2M (8, 37, 54, 55). Early studies 
reported the specific binding  of a2M to fibroblasts  (9, 52), 
and it was recognized  that the binding  of ot2M to cells was 
specific for the forms of ~2M activated either by proteolysis 
or by reaction with methylamine (23, 32, 52). Despite the 
widespread use of ot2M in studying the process of endocyto- 
sis,  little  is known about the polypeptide composition and 
structure of the o~2M receptor.  A more comprehensive un- 
derstanding  of the function  of the ot2M receptor requires a 
knowledge of the structure of this molecule.  The present in- 
vestigation  was initiated  to characterize  the o~2M receptor. 
Materials and Methods 
Proteins 
~2M was prepared according to the method of Imber and Pizzo (23) fol- 
lowed by immunoaflinity chromatography (50) to remove trace amounts of 
the cleaved form when necessary. ~2M-trypsin complexes were prepared 
by reacting ~2M with a  1.8-fold molar excess (active site concentration) of 
trypsin.  Trypsin  activity  was  then  inhibited  with  20  mbl  diisopropyl 
fluorophosphate. ¢2M was iodinated with Enzymobeads (Bio-Rad Labora- 
tories, Richmond, CA). The specific radioactivity of  the labeled protein was 
1 i~Ciltzg protein. Upon activation with trypsin or with methylamine, SDS- 
PAGE followed by autoradiography of this material showed a distribution 
of products that was essentially identical to that obtained for unlabeled acti- 
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50). Mouse laminin was provided by Dr. Albert Chung (Department  of Bio- 
logical Sciences, University of Pittsburgh, Pittsburgh, PA). 
Preparation of  Methylamine-treated ozM 
(cr~M:Me)-Sepharose 
Native a2M (8.6 mg/mi) was incubated with 200 mM methylamine in 50 
mM sodium phosphate, 150 mM NaCI, pH 7.4, for I h at room temperature. 
The c~2M:Me was then dialyzed extensively against 0.1 M NaHCO3, 0.5 M 
NaCI, pH 8.3. After dialysis, the protein was coupled to CNBr-activated 
Scpharose 413  (Pharmacia  Fine  Chemicals,  Piscataway,  NJ)  as  recom- 
mended by the manufacturer using 10 mg c~2M:Me/ml resin. The coupling 
was allowed to proceed for 2 h at room temperature using end-over-end  mix- 
ing. After coupling, the solution was removed and replaced with 0.1 M Tris, 
pH  8.0, for an additional 2  h  at  room temperature. The resin was then 
washed extensively with alternating buffers of 0.1 M sodium acetate, 0.5 M 
NaCI, pH 5.0, and 0.1  M sodium bicarbonate, pH 8.3, 0.5 M  NaCI. 
Purification of the .zM Receptor 
All procedures, unless indicated, were carried out at 4°C. Fresh placenta, 
obtained from Montgomery General Hospital (OIney,  MD)  was washed 
with cold TBS (50 mM Tris, 150 mM NaCI, pH 7.4) and 200 mM sucrose. 
The fetal membranes and umbilical cord were removed, and the placenta 
was ground and either used immediately or stored at -20°C until needed. 
The tissue was suspended in an equal volume of TBS containing 0.005% 
digitonin, 1 mM each of MgCI2 and CaCI2,  and the following proteinase 
inhibitors: I mM PMSF, 0.02 mg/ml leupeptin, and 0.02 mg/ml n-Phe-Pro- 
Arg-Ch2CI. After stirring for 15 min on ice, the mixture was homogenized 
in a blender (three times for 30 s each) and then centrifuged at 5000 g for 
20 min. The supernatant was discarded, and the pelleted tissue was sus- 
pended in an equal volume of extraction buffer (50 mM octyl-B-D-gluco- 
pyranoside in TBS containing  1 mM each of MgCI2 and CaCI2,  1 mM 
PMSF, 0.02 mg/mi ieupeptin, 0.02 mg/ml o-Phe-Pro-Arg-Ch2Cl for 1 h at 
4°C or on ice. The suspension was subjected to centrifugation at 5,000 g 
for 20 min, and the supernatant from this step was subjected to additional 
centrifugation at 11,000 g for 20 min. The resultant supernatant was then 
applied to a  120-mi  Scpharose CL-4B column. The unabsorbed material 
from this column was mixed overnight at 4°C with 40-60 ml of the a2M: 
Me-Sepharose column.  The  resin was then washed with eight column 
volumes of 25  mM octyi-B-D-glucopyranoside in TBS containing 1 mM 
CaCI2,  1 mM MgCl2, 1 mM PMSE Elution was achieved using TBS con- 
mining  20  mM  EDTA,  25  mM  octyl-B-D-glucopyranoside.  Further 
purification was achieved by applying the eluate from this column to a Mono 
Q anion exchange column (Pharmacia Fine Chemicals) at room temperature 
previously equilibrated with 20 mM octyl-B-o-glncopyranoside  in 50 mM 
Tris, pH 8.2, at a flow rate of  0.5 mi/min. After washing the column, a linear 
gradient from 0 to I M NaCI was applied over 40 rain using a Waters Instru- 
ments, Inc. (Rochester, MN) 650E advanced protein purification system. 
Protein was monitored at 280 rim, and l-ml fractions were collected. Frac- 
tions containing the receptor were stored at 4°C and used for further studies. 
The concentration of the receptor was estimated by absorbance measure- 
ments at 280 nm assuming an EI~  2s° ,m of 10.0. 
SDS-PAGE 
A discontinuous pH gel system (Laemmli) was used with 4% polyacryl- 
amide stacking gel and a 5-15% separating gel (1.5 mm  x  16 cm x  13.5 
cm). Proteins were stained with Coomassie blue R-250. Before SDS-PAGE, 
samples were either reduced in SDS sample buffer with 50 mM DTT at 
50°C for 10 min or in SDS sample buffer with 1% ~-mereaptoethanol at 
100°C for 5 rain. 
Surface Labeling of Fibroblasts 
Normal rat kidney (NRK) fibroblasts (CRL 1570), obtained from the Amer- 
ican Type Culture Collection (Rockville, MD) were grown in a 75-mi flask 
in DME containing 5% heat-inactivated FCS with 1% penicillin/streptomy- 
cin and 1%  L-glutamine.  Cells (2.5  x  107) were removed from the flask 
with 2 mM EDTA, pH 7.4, counted, washed twice with serum-free DME, 
and then resuspended in 3-4 ml of 20 mM glucose in Dulbecco's PBS. The 
cells were concentrated by centrifugation and resuspended in I mi of  20 mM 
glncosedDulbecco's bufer. Glucose oxidase (0.4 U), lactoperoxidase (200 
~tg), and Nal2Sl (1 mCi) were then added and incubated with the cells for 
20 min on ice with frequent mixing. After this period, the cells were washed 
three times (3 ml each wash) with cold PBS, and resuspended in I ml of 
extraction buffer.  After stirring for 1 h at 4°C, the supernatant was mixed 
with  1 ml of ¢~2M:Me-Sepharose overnight. After washing, the column 
was eluted with a buffer containing 20 mM EDTA. 
Binding of  azM to the Purified 420-kD Protein 
Two assays were used to measure the binding activity of various fractions. 
The first assay measured the binding of afffinity-purified (50)  '25I-labeled 
c¢2M:Me (or cx2M) to micmtiter wells coated with either the purified recep- 
tor or with various column fractions. Coating was carried out in 50 mM 
Tris,  150 mM NaCl, 5 mM CaCI2,  pH 7.4,  and was allowed to proceed 
overnight at 4°C. After washing, the wells were blocked with 3% BSA and 
incubated with '2SI-labeled ¢xeM:Me (5-7 nM) in the presence of increas- 
ing concentrations of unlabeled c~2M or ¢x2M:Me. The buffer used was 50 
mM "Iris,  150 mM NaCi, 5 mM CaCle, 3% BSA, pH 7.4.  After a 2-h in- 
cubation at 4°C, the wells were washed and counted. Binding data were ana- 
lyzed as described by Munson and Rodbard (39)  using the computer pro- 
gram LIGAND. In some experiments, 12SI-labeled ~x2M-trypsin was used 
in place of c~2M:Me. The binding assay was shown to depend upon the 
concentration of  added ligand, upon the mass of protein coated to the micro- 
titer wells, and, further, on the form of ~2M used. An ELISA (10) was 
used to measure the specificity of various cxeM derivatives for the purified 
420-kD polypeptide. This assay was performed by coating wells of microti- 
ter plates (Immulon II; Dynatech Laboratories, Inc., Alexandria, VA) with 
100/~1 purified 420-kD polypeptide (5 t~g/ml) in coating buffer (Dulbecco's 
PBS plus 1 mM CaCI2)  for 6 h at room temperature. After washing with 
PBS, the plate was blocked with 10 mg/ml BSA in coating buffer for 1 h 
at room temperature. The plates were then washed with PBS containing 
0.05 % Tween 20, and various amounts of ~t2M or cqM-trypsin complexes 
diluted in PBS containing 0.05%  Tween 20,  10 mg/ml BSA, and  1 mM 
CaCI2  were added.  Incubation was carried out overnight at 4°C.  After 
washing, rabbit anti-human ~xeM (Boehringer Mannheim Biochemicals, 
Indianapolis, IN) diluted  1:10,000 was added, and detection was accom- 
plished using an anti-rabbit IgG-alkaline phosphatase conjugate. All ex- 
periments included control wells that contained no receptor coating. The 
data were analyzed according to the following relationship (24)" 
(  ILl 
A  =  A ....  ~), 
where A is the absorbance at 410 nm, Amax is the maximum absorbance at 
saturation and is treated as a variable parameter, [L] is the molar concentra- 
tion of free ~x2M or c~2M-trypsin,  and Kd is the dissociation constant. Ap- 
plication of this analysis to the present data assumes that the amount of 
added ligand is greater than the amount of receptor bound to the microtiter 
wells. This is especially true at higher ligand concentrations. Under these 
conditions, the concentration of free ¢x2M or cx2M-trypsin is approximately 
equal to the total concentration of c~2M or c¢2M-trypsin. 
Results 
A/Sniff Chromatography of 
Octyl-~-D-glucopyranoside Extracts from Placenta 
Binding studies have suggested that relatively large quanti- 
ties of o~M receptor are present in placenta (28).  This tis- 
sue is an abundant source of receptors for fibronectin (43), 
vitronectin (43), and transferrin (51). Consequently, studies 
were initiated to isolate the o~2M receptor from octyl-~-D- 
glucopyranoside extracts of human placenta. All procedures 
were carried out in the presence of proteinase inhibitors, and 
solubilization was performed in a buffer containing 50 mM 
octyl-~-D-glucopyranoside, 1 mM Ca  2÷, and  1 mM Mg  2÷. 
The extract was first applied to a Sepharose CL-4B column 
to remove any protein with an affinity  for this matrix and then 
applied to  an  affinity column prepared  by coupling ¢x2M 
previously reacted with methylamine (czeM:Me) to Sepha- 
rose CL-4B. After extensive washing, the column was eluted 
with metal-free buffer containing 20 mM EDTA. The elution 
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rose-ot2M:Me. (A) Elution profile after addition of buffer contain- 
ing 20 mM EDTA (solid line). Individual fractions were diluted 20- 
fold and coated to microtiter wells, and 5.0 nM t2Sl-ot2M-trypsin 
was added. After incubation and washing, the wells were counted 
(bars). Nonspecific binding was determined by adding a 200-fold 
molar excess of unlabeled ot2M-trypsin. (B) Polypeptide composi- 
tion of fractions eluted from the ~x2M:Me-Sepharose  affinity col- 
umn assessed by SDS-PAGE. Aliquots (20 #1) from each fraction 
were mixed with SDS sample buffer containing 50 mM IYI'T. After 
incubation,  the  samples were subjected to electrophoresis on a 
5-15%  gradient gel with a 4%  stacking gel using the Laemmli 
buffer system. (Lane 1) Standards; (lanes 2-6) fractions 4-8 from 
the affinity column. 
column was assessed by SDS-PAGE.  Representative data, 
shown in Fig. 1 B, reveals that three polypeptides (Fig. 1 B, 
arrows) are eluted from the affinity column.  Polypeptides 
with apparent molecular mass of 420 and 39 kD are the ma- 
jor proteins eluted from the affinity column. A third polypep- 
tide, with an apparent molecular mass of 90 kD is present 
in variable amounts in different preparations. In some prepa- 
rations,  this polypeptide can be readily detected by SDS- 
PAGE (e.g., Fig. 1 B), while in other preparations (e.g., Fig. 
2, lane 1 ) only trace levels are present. The variable amounts 
of the 90-kD polypeptide in different preparations support 
the contention that this protein is not exclusively responsible 
to the binding activity. The data shown in Fig. 1 B represent 
SDS-PAGE under reducing conditions. Analysis of the sam- 
ples under nonreducing conditions revealed that none of the 
polypeptides are covalently linked by disulfide bonds. 
Binding studies have documented that cells bind specif- 
ically to the activated forms of ¢x2M (32, 52). These forms 
occur after reaction  of ot2M with  either  methylamine or 
proteinases. To examine the specificity of  the 420- and 39-kD 
polypeptides for various  ¢x2M conformers, a  portion of a 
placental extract was applied to an affinity column consisting 
of native a2M  coupled to Sepharose.  In a  control experi- 
ment, an equal portion was applied to an cx2M:Me affinity 
column. Fig. 2  shows an analysis of the eluted proteins by 
SDS-PAGE and demonstrates that the 420- and 39-kD poly- 
peptides (Fig. 2, arrows) are specific for the activated forms 
of c~2M (Fig. 2, lane 1) and do not bind to native c~2M (Fig. 
2,  lane 2).  Preincubation of the ~x~M:Me affinity column 
with stoichiometric amounts of monoclonal antibody 7H11D6 
reduces the amount of  both the 420- and 39-kD polypeptides 
recovered from the column (data not shown). This monoclo- 
nal antibody binds to the region of c~2M that is involved in 
cell recognition (25,  50). 
The requirement of metal ions for the binding of this pro- 
tein to immobilized c~2M:Me is in agreement with the known 
requirement of metal ions for the binding of cz2M:Me and 
c~2M-proteinase  complexes to cells (11, 13,  18, 32, 40, 42, 
52). Many ligands, such as o~2M-proteinase  complexes, that 
enter the cell by receptor-mediated endocytosis are delivered 
to lysosomes, while their receptors are recycled back to the 
cell surface (5). This mechanism requires that the receptor- 
ligand complex dissociate, which for a number of receptor 
systems is presumably the result of lowering of the pH. The 
interaction of activated c~2M with cells (36) and with solubi- 
lized membranes (15) is pH dependent, with maximal bind- 
ing occurring between pH 7 and 8 and a reduction in affinity 
profile from the affinity column is depicted in Fig.  1 A. Di- 
lute aliquots of each fraction were adsorbed onto microtiter 
wells and tested for their ability to bind t25I-labeled ot~M- 
trypsin complexes. Nonspecific binding, determined by in- 
cluding a 200-fold molar excess of unlabeled ot~M-trypsin 
with the labeled ligand, was '~9 % of  total binding. The bind- 
ing activity measured by this assay correlated with the total 
protein eluted from the column, and the presence of specific 
binding in these fractions indicates that it is possible to re- 
constitute binding activity. 
The polypeptide content of each fraction from the affinity 
Figure 2. Analysis of proteins derived from 
affinity  chromatography  of placental extracts 
on immobilized c~2M:Me (lane 1) or im- 
mobilized  native  ot2M (lane  2)  by  SDS- 
PAGE. 15-ml extracts were applied to l-ml 
columns, incubated overnight at 4°C, and 
washed. After washing, the columns were 
eluted in a buffer containing 20 mM EDTA. 
Equal volumes (65 #1) of the eluted frac- 
tions were analyzed by SDS-PAGE under 
reducing conditions on 5-15% gradient gels. 
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Figure 3.  Binding of ~25I-labeled  u2M:Me to the immobilized re- 
ceptor preparation obtained from  the a2M:Me affinity column. 
Microtiter wells, coated  with receptor, were incubated with 4.9 nM 
'251-]abeled ct2M:Me in the presence of increasing concentrations 
of unlabeled a2M:Me.  The curve displays the best fit of the data 
to a single class of sites with a Kd of 10 nM. Each point represents 
the average  of duplicates. 
majority of the 90-kD polypeptide, when present, does not 
bind to the Mono Q  resin,  and is present with the 39-kD 
polypeptide. 
A  comparison of the binding of '~5I-ot2M-trypsin to the 
various fractions derived from the anion exchange column is 
shown in Fig. 5. In these experiments, the purified 420-kD 
polypeptide and a pool of the unabsorbed fractions from the 
Mono Q  column containing the  39-kD  polypeptide were 
coated to microtiter wells. As a control, material recovered 
from the o~2M:M¢ affinity column was also included.  ,2q_ 
ot2M-trypsin (5 nM) was then added in the absence (Fig. 5, 
solid bars) or presence (Fig. 5, open bars) of a 200-fold mo- 
lar excess of unlabeled tx2M-trypsin. After incubation and 
washing, the amount of labeled tx2M-trypsin bound to each 
well was  measured.  The results confirm that the 420-kD 
polypeptide specifically binds c~2M-trypsin complexes. Very 
as the pH decreases below 6.0. Consistent with this is the ob- 
servation that  the 420- and  39-kD polypeptides could be 
eluted from the affinity resin with a pH 5.0 sodium acetate 
buffer. 
Since it is possible to reconstitute binding activity after 
elution  from  the  immobilized  a2M:Me  column,  experi- 
ments were conducted to measure the affinity of this material 
for ot2M:Me.  Fig.  3 demonstrates the results of an experi- 
ment in which a  constant amount of ~2q-labeled c~zM:Me, 
with increasing amounts of unlabeled azM:Me, is added to 
microtiter wells coated with the material eluted from the 
affinity column. The curve in Fig. 3 represents the best fit 
of the data to a single class of sites using the procedure de- 
scribed by Munson and Rodbard (39), and a Ks of 10 nM 
was derived from the fit.  In several different c~2M receptor 
preparations,  values of the Ks  ranged  from 2  to  14  riM. 
These values are relatively close to those values of  0.2-10 nM 
reported for the binding of a2M:Me to various cells (11, 13, 
15,  17, 48). 
Demonstration That the Binding Activity Is 
Associated with the 420-kD Polypeptide 
The  following experiments  were  conducted  to  determine 
which of the polypeptides eluted from the c~2M:Me affinity 
column is responsible for the binding activity. No binding of 
~25I-a2M:Me to  any  polypeptide was  detected after SDS- 
PAGE and transfer to immobilon. An additional chromatog- 
raphy step was used to separate the components eluted from 
the affinity column.  This was  accomplished by anion ex- 
change chromatography on a  Mono-Q column (Fig. 4 A). 
The ot2M-trypsin binding activity was associated with those 
fractions that were eluted with 0.5-0.6 M NaCl. Examination 
of  individual fractions by SDS-PAGE (Fig. 4 B) revealed that 
these fractions contain the 420-kD polypeptide (Fig. 4  B, 
lanes 4-7). The 39-kD fragment does not bind to the column 
(Fig.  4,  lane 2).  Additional experiments revealed that the 
Figure 4. (A) Separation of the 420- and 39-kD polypeptides by an- 
ion exchange chromatography on a Mono Q column. The flow rate 
was 0.5 ml/min, and 1-ml fractions were collected. For assay, frac- 
tions were diluted 40-fold, coated to microtiter wells, and incubated 
with 5 nM '25I-c~2M-trypsin. After incubation and washing, the 
wells were counted (bars). Nonspecific binding was determined by 
adding a 200-fold molar excess of unlabeled t~2M-trypsin. (8) 
Analysis of selected fractions by SDS-PAGE on 5-15 % gradient 
gels. (Lanes 1-7, respectively) Material loaded on the column, pool 
of fractions %14, fraction 35, fraction 37, fraction 39, fraction 41, 
and fraction 43. In lanes 1 and 2, 40-~1 aliquots were applied to 
the gels, while, in lanes 3-7, 10-~1 aliquots were applied. 
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Figure 5.  Comparison of the binding of ~25I-labeled ~x2M-trypsin 
to the purified 420-kD polypeptide and the 39-kD polypeptide. Mi- 
crotiter wells were coated with 100 #1 of 420-kD polypeptide (21 nM) 
or 100 #1 of 39-kD polypeptide (34 nM). After washing, the wells 
were incubated with 5  nM 125I-c~2M-trypsin  in the absence (solid 
bars) or presence of a  1 #M unlabeled ot2M-trypsin (open bars). 
After incubation overnight at 4°C, the wells were washed and count- 
ed. As a control, binding to the material derived from the c~2M:Me 
affinity column is also shown. 
little binding of these complexes to microtiter wells coated 
with the 39-kD polypeptide occurs. 
The  experiments  presented  in  Fig.  5  indicate  that  the 
purified 420-kD  polypeptide specifically binds  ~25I-ot2M- 
trypsin complexes whereas the 39-kD polypeptide does not 
bind these complexes. A comparison of the binding activity 
of  the purified 420-kD receptor with the material eluted from 
the affinity resin is best accomplished by a comparison of the 
Ka values for these two samples. Fig. 6 demonstrates the re- 
suits of  a binding experiment using the purified 420-kD poly- 
peptide. A K~ of 57 nM was determined from a best fit of 
the data to a single class of sites. This value is slightly higher 
than the Ko measured for the material recovered from the 
affinity column and most likely reflects the fact that optimal 
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Figure 6. Binding of 125I-labeled ct2M:Me to the purified receptor 
preparation obtained after anion exchange chromatography. Micro- 
titer wells, coated with receptor, were incubated with 7 nM 125I- 
labeled t~2M:Me in the presence of increasing concentrations of 
unlabeled ct2M:Me. The curve displays the best fit of the data to a 
single class of sites with a Kd of 57 nM. Each point represents the 
average of duplicates. 
reconstitution conditions have not been achieved. Binding 
experiments, in which the purified 39- and 420-kD polypep- 
tides were mixed before assay,  suggest that the 39-kD poly- 
peptide has little influence on the affinity of the 420-kD poly- 
peptide for 12~I-labeled ot2M-trypsin. 
Specificity  of the Purified Placental Protein for 
ctzM-Proteinase Complexes 
An ELISA (10) was used to measure the specificity of the 
purified 420-10) polypeptide. For these experiments, affin- 
ity-purified native ct2M (50) was used to ensure no contam- 
ination of this form with the proteolyzed form. The results 
of these experiments (Fig. 7) demonstrate the specific bind- 
ing of activated c~2M to microtiter wells coated with  the 
purified 420-kD polypeptide. Very little binding of native 
c~2M to the 420-kD protein was detected. Furthermore, no 
binding of any form of ot2M to wells coated with BSA or 
with the purified human fibronectin receptor was observed. 
Thus, the purified placental protein demonstrates a similar 
specificity to that documented in studies examining the bind- 
ing of derivatives of c~2M to cells. The data reveal that the 
solid phase binding approaches saturation (Fig. 7, inset) and 
when fit to a single class of binding sites (Fig. 7, solid line) 
yielded an estimate for the Kd of 70 nM.  This value is in 
good agreement with the K~ determined from the displace- 
ment experiments described earlier. 
Estimate of the Size of the Purified ooM 
Receptor and Demonstration That This Polypeptide 
Is a Glycoprotein 
Fig.  8 A shows an analysis of the purified polypeptide by 
SDS-PAGE. Comparison of its relative mobility with that of 
the reduced laminin A  chain (,,o400 kD) confirm that this 
protein is unusually large.  Extrapolation of the molecular 
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Figure 7.  Specificity of the purified ot2M receptor for activated 
ot2M. The binding of native ot2M (4) or ot2M-trypsin complexes 
(e) to mirotiter wells coated with purified 420-kD polypepfide  were 
measured. Control experiments show the binding of ot2M-trypsin 
complexes to microtiter wells coated with BSA (A) or with the 
fibronectin receptor (i). The binding of native ot2M to BSA and 
the fibronectin receptor was identical to that shown for ot2M-tryp- 
sin complexes. (Inset) Replot of the data in the form used for the 
fitting process. Solid line in both graphs represents the best fit of 
the data to a single class of sites, giving a Kd of 70 nM and Am,, 
of 1.33. 
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an apparent molecular mass of 420 kD under reducing con- 
ditions. Under nonreducing conditions, the mobility of the 
o~2M receptor increases  slightly,  suggesting that the poly- 
peptide has several  internal disulfide bonds. In one experi- 
ment (not shown), the 420-kD polypeptide was transferred 
to immobilon and stained with anti-human o~2M or anti- 
human laminin antibodies. These studies revealed that the 
placental protein is not related to any form of ot2M or lami- 
nin. The presence of carbohydrate on the 420-kD polypep- 
tide was determined by chromatography over immobilized 
wheat germ agglutinin. The 420-kD polypeptide was bound 
to this resin and could be eluted with 0.5 M N-acetyl-D-glu- 
cosamine.  All of the ct2M-proteinase binding ability was 
eluted with the 420-kD polypeptide. 
IdenU'fication of a 420-kD Polypeptide from 
Affinity Chromatography of  Surface-labeled Proteins 
from NRK Fibroblasts 
Surface labeling experiments were performed to determine 
if the 420-kD protein is located on the cell surface. NRK 
fibroblasts were chosen for these experiments since the bind- 
ing of u2M-proteinase complexes to this cell line is well 
characterized.  Cell  surface proteins  were  iodinated using 
lactoperoxidase. After washing, the cells were solubilized 
and  applied  to  the  ct2M:Me-Sepharose  affinity column. 
Fig. 8 B demonstrates an analysis of the material eluted from 
the  affinity resin  after  SDS-PAGE  and  autoradiography. 
These results indicate that NRK fibroblasts contain a surface 
protein with a similar electrophoretic mobility to the human 
placental protein. 
Discussion 
The general interest in the mechanism of receptor-mediated 
endocytosis has prompted a number of studies describing the 
uptake, internalization, and degradation of various deriva- 
tives of t~2M (8, 14, 27, 29, 30, 37, 54, 55). These investiga- 
tions have yielded considerable insight into mechanisms in- 
volved in endocytosis. Despite some insight into the role of 
the o~2M receptor in this process, information on its struc- 
ture is extremely limited. The present studies were initiated 
with the goal of deriving information on this receptor sys- 
tem. Binding studies have reported the existence of a large 
number of a2M receptors in placental syncytiotrophoblasts 
(28).  This observation, combined with the fact that the pla- 
centa has large quantities of receptors for a variety of pro- 
teins (43, 46, 51), suggested that this tissue might be an excel- 
lent source for the isolation of relatively large quantities of 
this receptor.  Affinity chromatography was used to inves- 
tigate the u2M receptor from this tissue. 
This approach identified two polypeptides, with apparent 
molecular masses of 420  and 39 kD,  that are specifically 
bound to  an affinity column prepared  by  reacting  native 
o~2M with methylamine. The specificity of these two com- 
ponents for the conformationally altered form of tx2M was 
documented by demonstrating that these polypeptides did 
not bind to a column prepared by coupling native ct2M to 
Sepharose.  Additional chromatography steps were used to 
separate these two components, and the results of these ex- 
periments indicated that the binding activity was associated 
Figure 8. (.4)  Estimate of the size of the purified receptor by SDS- 
PAGE under reducing conditions on a 5 % gel. (Lane 1) Standards, 
which include  myosin,  ~-galactosidase,  phosphorylas¢  b, BSA, and 
ovalbumin; (lane 2) purified a2M receptor. The migration position 
of the c~2M subunit and the A and B chains of laminin are also 
shown. (B) SDS-PAGE analysis  oftbe material  eluted from  ~2M:Me 
affinity chromatography after  surface labeling of proteins from 
NRK fibroblasts. The migration position of standard proteins are 
shown. 
with the 420-kD  polypeptide.  Considerable evidence has 
been obtained that indicates that this polypeptide has proper- 
ties of the ot~M receptor. Most important, the purified gly- 
coprotein exhibits an identical specificity and a similar high 
affinity for the activated form of ct2M that is displayed by 
the binding of tx2M derivatives to cells. Very little, if any, 
binding of  the purified protein to the native molecule was ob- 
served in the present  study.  Second,  the purified protein 
demonstrates a  similar requirement for metal ions, and a 
similar pH dependence for binding,  that is found for the 
binding of proteolyzed a2M to cells. Third, surface labeling 
experiments indicate that the 420-kD polypeptide is located 
on the surface of fibroblasts.  All of these data provide com- 
pelling evidence that the 420-kD  glycoprotein is  an t~2M 
receptor. 
At this time, the relationship between the 420- and 39-kD 
polypeptides is not known. The 39-kD polypeptide, like the 
420-kD polypeptide, does not bind to native ot2M immobi- 
lized on Sepharose and thus is specific for the affinity  column 
containing  activated  t~2M. Interestingly,  this  polypeptide 
does not appear to bind directly to mI-labeled ot2M-trypsin 
or ct2M:Me. These results suggest that the 39-kD polypep- 
tide is associated with the 420-kD  polypeptide and could 
represent either a subunit of the ot2M receptor or, possibly, 
a cytosolic protein that binds to the o~2M receptor. Further 
experiments are required to determine the potential interac- 
tion between these two components and the significance of 
this interaction. 
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complexes (or the methylamine-reacted form) to cells have 
resulted in nonlinear Scatchard plots. The data have been in- 
terpreted to represent two classes of binding sites.  At this 
time it is not clear if  these two binding sites represent distinct 
molecules  or,  as  suggested  (18),  whether  they represent 
ligand binding to aggregated receptor molecules with high 
affinity and to single receptor molecules with a lower affinity. 
The binding affinity for the purified receptor recovered from 
the affinity  column is similar to that measured for the binding 
of ~2~I-labeled ot~M-trypsin complexes to solubilized mem- 
branes (15, 18). Further purifcation of the c~2M receptor by 
anion exchange chromatography results in a molecule with 
a reduced binding affinity. It is quite likely that the methods 
used  in  the present study,  in which microtiter wells are 
coated with purified receptor,  are  not optimal for recep- 
tor-ligand binding. This is particularly true if aggregation of 
the receptor is required for high affinity binding. Further, 
reconstitution of the receptor into appropriate phospholipid 
vesicles would likely result in an increased affinity of the 
420-kD  polypeptide  for  ligand.  Studies  are  currently  in 
progress to examine these and other possibilities. The fact 
that  ot2M contains four identical subunits and the observa- 
tion that ot~M appears  to be a  multivalent ligand for the 
receptor (53) further complicates interpretation of the bind- 
ing interaction. 
The large size of the c~2M receptor in the present study 
differs from some previous reports. Three reports in the liter- 
ature  have  described  the  partial  purification of the  ot2M 
receptor  from  membranes  of spontaneously transformed 
fibroblasts (NIH-3T3  cells)  (17) and from human diploid 
fibroblasts (12, 35). There does not appear to be any general 
consensus as to the  identity of this molecule from these 
reports. Hanover et al. (17, 19) identified two polypeptides 
(90 and 180 kD) as potential candidates for the t~2M recep- 
tor. A second study (12) identified a single 125-kD compo- 
nent that appeared to bind to t25I-ot2M-trypsin complex af- 
ter  transfer  of  the  polypeptide  to  nitrocellulose.  Using 
affinity chromatography over immobilized a~M:Me, Mary- 
nen et al. (34) identified three components from 3~S-labeled 
normal human fibroblasts with molecular masses of 360, 
130, and 83 kD as the putative t~2M receptor. The largest of 
these polypeptides has a molecular mass close to that ob- 
tained in the present study. The relationship between these 
proteins and the large single chain molecule identified in the 
present study remains to be determined. It is likely that some 
or all of these polypeptides may represent degradation prod- 
ucts of the larger polypeptide, and it does not appear likely 
that fibroblasts contain a different  and much smaller molecu- 
lar mass receptor than that isolated in the present study since 
studies with surface-labeled fibroblasts identified a large mo- 
lecular mass component as the major protein eluted from an 
ot2M:Me affinity column. An 85-kD polypeptide was noted 
in some of the receptor preparations in the present studies. 
The presence of only trace amounts of this polypeptide in 
most preparations suggest that it is not responsible for the 
binding activity. It is possible that this polypeptide arises as 
a proteolytic product of the larger 420-kD polypeptide. This 
proposal is supported by Jensen and Pizzo (26) who noted 
an accumulation of an 80-90-kD polypeptide upon storage 
of their receptor preparation for several days. Further, incu- 
bation  of the  purified 420-kD  polypeptide  with elastase 
(Cravens, J. L., and D. K. Strickland, unpublished observa- 
tion) in the present study yielded several polypeptides with 
apparent molecular masses in the 66-90-kD range in addi- 
tion to other distinct polypeptides. These results indicate that 
it is possible to generate fragments with similar molecular 
masses by proteolysis of the purified 420-kD polypeptide. 
In excellent agreement with the present work is a report 
(15) examining the functional molecular mass of the c~2M 
receptor by radiation inactivation. This approach, in con- 
junction with cross-linking studies, concluded that the c~2M 
receptor is a large polypeptide with a molecular mass rang- 
ing from 420 to 500 kD. During the preparation of the pres- 
ent manuscript, two studies appeared in the literature de- 
scribing large molecular mass polypeptides as components 
of the cteM receptor.  The size of these polypeptides, iso- 
lated from human, baboon, rat, and mouse liver (26)  and 
from rat liver membranes (38),  agree with the size of the 
o~2M receptor in the present investigation. 
Few receptors have subunits as large as the ~t2M receptor 
identified in the present study. It is considerably larger than 
other  well  characterized  receptors  involved in  receptor- 
mediated endocytosis. For example, the transferrin receptor 
is a dimer of 90 kD (44), while the low density lipoprotein 
receptor appears to be a single chain of 164 kD (45).  The 
CR1 (C3b/C4b) receptor, a molecule that binds to proteins 
closely related to ot~M (47),  is a polymorphic polypeptide 
(33) with a  relatively large molecular mass (ranging from 
160 to 250 kD). This receptor was found to contain 30 do- 
mains containing the short consensus repeat units also found 
in  C4b/C3b  binding  protein  (33).  Herz  et  al.  (21) have 
identified a large 500-kD  liver membrane protein, closely 
related to low density lipoprotein receptor, whose function 
remains undefined. It is quite possible that a family of large 
molecular mass receptors exists on a variety of cells. The 
availability of large amounts of homogenous ct2M receptor 
will  facilitate  structural  determination  of  this  molecule 
which will be of  great value in establishing the role and func- 
tion of this receptor. 
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